DP072 | IGHV AND TP53 MUTATIONAL STATUS AT DIAGNOSIS: IMPACT ON OUTCOME IN PATIENTS WITH SPLENIC MARGINAL ZONE LYMPHOMA

Introduction: Splenic Marginal Zone Lymphoma (SMZL) is an rare, indolent B-cell non-Hodgkin Lymphoma (NHL). Limited data are available on the impact of immunogenetics and TP53 mutations on SMZL outcomes. Methods: We explored the Immunoglobulin Heavy Chain Variable (IGHV) rearrangement status and TP...

Full description

Bibliographic Details

Published in:	Haematologica
Main Authors:	E. Cappello, S. Zibellini, C. Varraso, V.V. Ferretti, S. Rattotti, M. Varettoni, G.V. Facchetti, G. Favrin, C. Cavalloni, M. Gotti, R. Sciarra, A. Mazzacane, F. Carpi, M.C. Berliner, S. Pedrali, A. Mori, M. La Fauci, C. Picone, G. Neri, E. Boveri, M. Lucioni, M. Paulli, L. Arcaini
Format:	Article
Language:	English
Published:	Ferrata Storti Foundation 2025-09-01
Online Access:	https://haematologica.org/article/view/12732